Cargando…
Src is the primary target of aripiprazole, an atypical antipsychotic drug, in its anti-tumor action
Aripiprazole (ARP) is an atypical anti-psychotic drug widely used to treat schizophrenia and bipolar disorder. The pharmacological effects of ARP on cancer cells are still poorly understood. In this study, anti-cancer effects of ARP on various malignant tumor cells and its molecular mechanism were f...
Autores principales: | Kim, Mi Seon, Yoo, Byong Chul, Yang, Woo Seok, Han, Sang Yun, Jeong, Deok, Song, Jun Min, Kim, Kyung Hee, Aravinthan, Adithan, Kim, Ji Hye, Kim, Jong-Hoon, Kim, Seung Cheol, Cho, Jae Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814188/ https://www.ncbi.nlm.nih.gov/pubmed/29464048 http://dx.doi.org/10.18632/oncotarget.23192 |
Ejemplares similares
-
Anti-inflammatory effect of torilidis fructus ethanol extract through inhibition of Src
por: Park, Gyubyung, et al.
Publicado: (2017) -
Immunotoxicological Effects of Aripiprazole: In vivo and In vitro Studies
por: Baek, Kwang-Soo, et al.
Publicado: (2015) -
Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018) -
Efficacy and Tolerability of Aripiprazole: A 26-Week Switching Study from Oral Antipsychotics
por: Lee, Jung-Sun, et al.
Publicado: (2010) -
Dehydroabietic Acid Suppresses Inflammatory Response Via Suppression of Src-, Syk-, and TAK1-Mediated Pathways
por: Kim, Eunji, et al.
Publicado: (2019)